Trends in price for topical corticosteroids from 2017 to 2021 and the opportunity for cost savings identifiable at the point of care: A retrospective cross-sectional study
Recommended Citation
Kwa M, Guttentag A, Chase L, van Meijgaard J, and Lim HW. Trends in price for topical corticosteroids from 2017 to 2021 and the opportunity for cost savings identifiable at the point of care: A retrospective cross-sectional study. J Am Acad Dermatol 2023.
Document Type
Article
Publication Date
1-1-2024
Publication Title
Journal of the American Academy of Dermatology
Abstract
BACKGROUND: Topical corticosteroids possess numerous generics and similar-strength substitutes. Affordability can impact obtaining the medication prescribed.
OBJECTIVE: To determine recent trends in topical corticosteroid pricing and potential for cost saving.
METHODS: A retrospective cross-sectional study analyzing all prescriptions dispensed for topical corticosteroids from January 1, 2017 through December 31, 2021, using a US all-payer pharmacy-claims database and commercial coupon dataset, was performed.
RESULTS: Two hundred thirty-seven unique drug products (≥1 claim) were identified. Factors that predicted for higher cost (P < .05) were branded products (105% more expensive than generics) and ultrapotent class (55% more expensive than low potency) while ointments predicted for lower cost (19% less expensive than creams). Cash prices remained relatively stable, except for ultrapotent branded topical corticosteroids (63% increase). Cost savings were available for both brand-to-generic ($14.75 per unit) and generic-to-generic ($6.82 per unit) switching. Coupon prices were consistently lower than cash prices (r = 0.89).
LIMITATIONS: Contracted rates through insurance plans were not included.
CONCLUSIONS: Topical corticosteroid prices over the past 5 years have stabilized, the exception being branded ultrapotent corticosteroids. Savings from switching among similar-strength substitutes remain significant despite price stabilization. Coupon prices mirror the hierarchy of cash prices and can help assess real-time costs.
Medical Subject Headings
Humans; Cost Savings; Cross-Sectional Studies; Drug Costs; Retrospective Studies; Point-of-Care Systems; Dermatologic Agents; Adrenal Cortex Hormones; Drugs, Generic
PubMed ID
37730020
ePublication
ePub ahead of print
Volume
90
Issue
1
First Page
74
Last Page
81